{
    "title": "CVS tempers 2024 profit forecast on elevated medical costs, shares fall",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12697327/CVS-profit-beats-estimates-strong-performance-pharmacy-segment.html",
    "date": "2023-11-01",
    "keywords": [
        "forecast",
        "insurance",
        "business",
        "share",
        "cvs",
        "health",
        "healthcare",
        "pharmacy",
        "leo",
        "mariam",
        "wednesday",
        "company",
        "utilization",
        "street",
        "quarter",
        "pbm",
        "drug",
        "revenue",
        "growth",
        "corp",
        "unit",
        "half",
        "august",
        "medicare",
        "analyst",
        "ann",
        "time",
        "conglomerate",
        "aetna",
        "uncertainty",
        "performance",
        "plan",
        "industry",
        "year",
        "benefit",
        "ratio",
        "percentage",
        "companys",
        "thirdquarter",
        "profit",
        "beat",
        "strength",
        "management",
        "caremark",
        "specialty",
        "scrutiny",
        "role",
        "trade",
        "commission",
        "consumer",
        "wellness",
        "segment",
        "prescription",
        "volume",
        "day",
        "threeday",
        "pharmageddon",
        "staff",
        "sunny",
        "bengaluru",
        "editing",
        "chakrabarty",
        "vinay",
        "dwivedi"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}